Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pro-DexPDEX -0.03%66 3-Year Book Growth Rate is 16.70% as of Mar. 2026, which is 44% above its 10-year median of 11.60. GuruFocus rates PDEX with a GF Score™ of 66/100 and a GF Value™ of $40.81 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 759 Medical Devices & Instruments companies, Pro-Dex ranks better than 84.06% on this metric.
During the past 12 months, Pro-Dex's average Book Value per Share Growth Rate was 30.70% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 16.70% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 18.10% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 18.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Pro-Dex was 88.60% per year. The lowest was -39.30% per year. And the median was 11.60% per year.
Pro-Dex (NAS:PDEX) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Pro-Dex 3-Year Book Growth Rate Related Terms
PDEX vs KRMD, EMBC, UTMD: 3-Year Book Growth Rate Comparison
For the Medical Instruments & Supplies subindustry, Pro-Dex's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pro-Dex 3-Year Book Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pro-Dex's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Pro-Dex's 3-Year Book Growth Rate falls into.
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 16.70% mean?
Pro-Dex (PDEX) has a 3-Year Book Growth Rate of 16.70% as of Mar. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Pro-Dex and its competitors. This is 44% above median its historical median of 11.60. According to the industry distribution chart, Pro-Dex ranks #121 out of 759 companies in the Medical Devices & Instruments industry, placing it in the top 15.9%.
Is Pro-Dex's 3-Year Book Growth Rate too high?
Pro-Dex's current 3-Year Book Growth Rate of 16.70% is 44% above median its 10-year median of 11.60. The Medical Devices & Instruments industry median 3-Year Book Growth Rate is 2.30. Pro-Dex's value of 16.70% is 626.1% above this industry median. Based on the distribution chart, Pro-Dex ranks #121 out of 759 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Pro-Dex has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pro-Dex's 3-Year Book Growth Rate compare to KRMD and EMBC?
According to the Medical Devices & Instruments industry distribution chart, Pro-Dex ranks #121 out of 759 companies for 3-Year Book Growth Rate. This places Pro-Dex in the top 16% of its industry — outperforming the majority of peers. The industry median 3-Year Book Growth Rate is 2.30. Pro-Dex's value of 16.70% is 626.1% above this benchmark. While the company's 10-year median is 11.60 vs. the industry median of 2.30, Pro-Dex has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Medical Devices & Instruments company?
The median 3-Year Book Growth Rate among Medical Devices & Instruments companies is 2.30, based on 759 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pro-Dex's current 3-Year Book Growth Rate of 16.70% is 626.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Pro-Dex and its competitors. For the Medical Devices & Instruments industry, the median 3-Year Book Growth Rate is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pro-Dex's current 3-Year Book Growth Rate is 16.70%, which is 44% above median its own 10-year median of 11.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro-Dex stock overvalued right now?
Based on GuruFocus' analysis, Pro-Dex (PDEX) is currently considered Significantly Overvalued. The stock's GF Value™ is $40.81, compared to a current price of $66.76 — trading 63.6% above its estimated fair value. The current 3-Year Book Growth Rate is 16.70%, which is 44% above median its 10-year median of 11.60 and 626.1% above the Medical Devices & Instruments industry median of 2.30. Pro-Dex's overall GF Score™ is 66/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Pro-Dex (PDEX), the current 3-Year Book Growth Rate is 16.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pro-Dex (PDEX) Overvalued in 2026?
Based on GuruFocus' analysis, Pro-Dex stock appears to be overvalued.
The current stock price of $66.76 is trading 63.6% above its estimated GF Value™ of $40.81.
GuruFocus considers Pro-Dex to be Significantly Overvalued.
Key valuation signals for PDEX:
3-Year Book Growth Rate: 16.70% (44% above median its 10-year median of 11.60)
GF Value™: $40.81 vs. price of $66.76 (63.6% above fair value)
Industry Position: 626.1% above the Medical Devices & Instruments median (#121 of 759)
No single metric tells the full story. See the PDEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
66GF Score
Get the complete analysis for PDEX
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PDEX has been successfully added to your 
